Portfolio Details

GreenLight Biosciences, Inc.

Greenlight Biosciences company logo
Current
GreenLight is a bio-performance company with a unique, cell-free production platform that delivers high-performing RNA solutions to human, plant and animal challenges.
Learn more about the company
Greenlight Biosciences company logo
Current
Team
Venture Capital
Invested Date
January 2019
Status
Active
Location
U.S.

Share

See All Transactions

Related Content

Dropper adding sample to a test tube
GreenLight Biosciences Goes Public

Baird Capital portfolio company GreenLight Biosciences (GreenLight) officially started trading on Nasdaq as a public company.

Abstract blue shapes
GreenLight to Become Publicly Traded Company

The transaction hopes to advance GreenLight’s breakthrough biomanufacturing platform.

GreenLight Raises $102M Series D Round

Baird Capital portfolio company GreenLight Biosciences (GreenLight) announced it raised an oversubscribed $102 million Series D round of funding from new and existing investors.

Medical professional holding iPad while wearing lab coat
GreenLight Raises $17M for COVID-19 Vaccine Production

GreenLight Biosciences announced it had closed an oversubscribed $17M special purpose funding round to build out its scalable mRNA production capability targeting the production of billions of doses of COVID-19 vaccine.